Literature DB >> 486129

Effects of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor or ornithine decarboxylase, on testosterone-induced regeneration of prostate and seminal vesicle in castrated rats.

C Danzin, M J Jung, N Claverie, J Grove, A Sjoerdsma, J Koch-Weser.   

Abstract

1. Castration of adult rats markedly decreases the amounts of polyamines (putrescine, spermidine and spermine) and of RNA and DNA in the ventral prostate and the seminal vesicle. 2. Daily injections of testosterone propionate to rats castrated 7 days previously increase polyamine and nucleic acid contents more rapidly in the seminal vesicle than in the ventral prostate. 3. After 7 days of androgen treatment, polyamine and nucleic acid contents of the seminal vesicle are significantly higher than those of intact animals. Nucleic acid, but not polyamine, contents return to normal values during the next 4 days of continued treatment. In the prostate, androgen treatment increases polyamine and nucleic acid contents to, but not above, normal values. 4. Repeated doses of alpha-difluoromethylornithine, a potent enzyme-activated irreversible inhibitor of ornithine decarboxylase, totally blocked the testosterone-induced increase of putrescine and spermidine in the ventral prostate and of putrescine in the seminal vesicle. They slowed significantly the accumulation of spermine in the ventral prostate and of spermidine in the seminal vesicle. alpha-Difluoromethylornithine also retarded the testosterone-induced accumulation of RNA in the ventral prostate. However, no clear correlation was apparent between accumulation of polyamines and of nucleic acids in the two organs. 5. alpha-Difluoromethylornithine markedly slows the testosterone-induced weight gain of the prostate, but not of the seminal vesicle. Cytological studies suggest that this effect on the prostate is due to inhibition of the androgen-induced restoration of the secretion content of prostatic acini.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 486129      PMCID: PMC1161088          DOI: 10.1042/bj1800507

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  FUNCTIONAL ULTRASTRUCTURE OF RAT PROSTATIC EPITHELIUM.

Authors:  D BRANDES; D P GROTH
Journal:  Natl Cancer Inst Monogr       Date:  1963-10

2.  Regulation of nucleic acid synthesis by androgens.

Authors:  C D KOCHAKIAN; D G HARRISON
Journal:  Endocrinology       Date:  1962-01       Impact factor: 4.736

3.  The effects of castration and androgen replacement on the nucleic acid composition, metabolism, and enzymatic capacities of the rat ventral prostate.

Authors:  W W BUTLER; A L SCHADE
Journal:  Endocrinology       Date:  1958-09       Impact factor: 4.736

Review 4.  Hormonal effects on cell proliferation in rat prostate.

Authors:  N Bruchovsky; B Lesser; E Van Doorn; S Craven
Journal:  Vitam Horm       Date:  1975       Impact factor: 3.421

5.  Polyamine levels in normal human serum. Comparison of analytical methods.

Authors:  F Bartos; D Bartos; D P Grettie; R A Campbell
Journal:  Biochem Biophys Res Commun       Date:  1977-04-25       Impact factor: 3.575

6.  Methyl glyoxal bis(guanylhydrazone) as a potent inhibitor of mammalian and yeast S-adenosylmethionine decarboxylases.

Authors:  H G Williams-Ashman; A Schenone
Journal:  Biochem Biophys Res Commun       Date:  1972-01-14       Impact factor: 3.575

7.  The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.

Authors:  N Bruchovsky; J D Wilson
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

8.  An automated micromethod for the quantitative analysis of di- and polyamines utilizing a sensitive high pressure liquid chromatographic procedure.

Authors:  L J Marton; O Heby; C B Wilson; P L Lee
Journal:  FEBS Lett       Date:  1974-04-15       Impact factor: 4.124

9.  On the purification of L-ornithine decarboxylase from rat prostate and effects of thiol compounds on the enzyme.

Authors:  J Jänne; H G Williams-Ashman
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

Review 10.  Polynucleotide polymerizations and prostate proliferation.

Authors:  H G Williams-Ashman; B Tadolini; J Wilson; A Corti
Journal:  Vitam Horm       Date:  1975       Impact factor: 3.421

View more
  11 in total

Review 1.  DFMO: targeted risk reduction therapy for colorectal neoplasia.

Authors:  Christina M Laukaitis; Eugene W Gerner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-08       Impact factor: 3.043

2.  Selectivity of polyamine involvement in hormone action on normal and neoplastic target tissues of the rat.

Authors:  A Manni; B Badger; J Lynch; L Demers
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

Review 3.  Influence of polyamines on membrane functions.

Authors:  F Schuber
Journal:  Biochem J       Date:  1989-05-15       Impact factor: 3.857

Review 4.  Targeting polyamines and inflammation for cancer prevention.

Authors:  Naveen Babbar; Eugene W Gerner
Journal:  Recent Results Cancer Res       Date:  2011

5.  Differential effects of 2-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the testosterone-induced growth of ventral prostate and seminal vesicles of castrated rats.

Authors:  K Käpyaho; A Kallio; J Jänne
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

6.  Effect on prostatic growth of 2-difluoromethylornithine, an effective inhibitor of ornithine decarboxylase.

Authors:  C Danzin; N Claverie; J Wagner; J Grove; J Koch-Weser
Journal:  Biochem J       Date:  1982-01-15       Impact factor: 3.857

7.  Antitumor effect of methylglyoxal bis(3-aminopropylamidinohydrazone), a new inhibitor of S-adenosylmethionine and ornithine decarboxylases, on human erythroid leukemia K562 cells.

Authors:  H Hibasami; T Tsukada; S Maekawa; M Sakurai; S Shirakawa; K Nakashima
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  Difluoromethylornithine irreversibly inactivates ornithine decarboxylase of Pseudomonas aeruginosa, but does not inhibit the enzymes of Escherichia coli.

Authors:  A Kallio; P P McCann
Journal:  Biochem J       Date:  1981-10-15       Impact factor: 3.857

9.  The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial.

Authors:  Anne R Simoneau; Eugene W Gerner; Ray Nagle; Argyrios Ziogas; Sharon Fujikawa-Brooks; Hagit Yerushalmi; Thomas E Ahlering; Ronald Lieberman; Christine E McLaren; Hoda Anton-Culver; Frank L Meyskens
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02       Impact factor: 4.254

10.  Polyamine profiles and growth properties of ornithine decarboxylase overexpressing MCF-7 breast cancer cells in culture.

Authors:  A Manni; R Wechter; R Grove; L Wei; J Martel; L Demers
Journal:  Breast Cancer Res Treat       Date:  1995-04       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.